Skip to main content
Premium Trial:

Request an Annual Quote

Sharfstein Starts Role as Acting FDA Commissioner

NEW YORK (GenomeWeb News) – Joshua Sharfstein, who recently was appointed by President Barack Obama to serve as deputy commissioner of the US Food and Drug Administration, this morning takes over as acting FDA commissioner.

Sharfstein will hold that title while confirmation hearings are held for Margaret Hamburg, who was named by Obama to head the agency.

He takes over the interim role from Frank Torti, who has served as acting FDA commissioner since January.

Sharfstein has been health commissioner for the city of Baltimore for the past three years. He also is a former investigator for the Government Reform and Oversight Committee, serving under Rep. Henry Waxman (D - Calif.).

Filed under

The Scan

Renewed Gain-of-Function Worries

The New York Times writes that the pandemic is renewing concerns about gain-of-function research.

Who's Getting the Patents?

A trio of researchers has analyzed gender trends in biomedical patents issued between 1976 and 2010 in the US, New Scientist reports.

Other Uses

CBS Sunday Morning looks at how mRNA vaccine technology could be applied beyond SARS-CoV-2.

PLOS Papers Present Analysis of Cervicovaginal Microbiome, Glycosylation in Model Archaea, More

In PLOS this week: functional potential of the cervicovaginal microbiome, glycosylation patterns in model archaea, and more.